Benign prostatic hyperplasia or hypertrophy (BPH) is a pathologic condition characterized by a cellular proliferation of stromal and epithelial components. BPH is not life-threatening, but it can be uncomfortable, embarrassing, and inconvenient for the patient. No single definition of BPH has gained universal acceptance, making it difficult for epidemiologists to accurately calculate its incidence and [...]
Radiofrequency ablation devices work by sending alternating current through the tissue. This creates increased intracellular temperatures and localized interstitial heat. When temperatures exceed 60°C, cell proteins rapidly denature and coagulate, resulting in a lesion. The lesion can be used to resect and remove the tissue or to simply destroy the tissue, leaving the ablated tissue [...]
The European market for ablation technologies shows considerable variation by modality and country, given the differences in adoption rates for the different modalities, the local practice patterns and other regional variations. Below is illustrated the distribution of the ablation market by modality across the major markets in Western Europe. Source: MedMarket DIligence, LLC; Report #A145, [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
The largest application for energy-based ablation devices is in cancer therapy, primarily using the radiation therapy modality. Following that is general surgery with its use of electrocautery and electrosurgical devices, RF ablation, cryotherapy, etc. Cardiovascular is thought to be third, even though cardiovascular is making the most noise in the medical press with RF and [...]
Below is a list of technologies in development at recently identified medtech startups during May to July: Single incision laparoscopic surgery and natural orifice transluminal endoscopic surgery. Medical device development company. Surgical instrumentation and osteogenic biomaterials for spine surgery. Clinical diagnostics including a noninvasive prenatal diagnostics. Laparoscopic surgical instrumentation. Ultrasonic breast cancer detection device. Technologies for [...]
With medical technology financing driven way over the top by the $151.5 million financing by Devicor Medical Products (acquirer of J&J's Ethicon Endo-Surgery breast-care business), the July 2010 total hit a year high-to-date $518.3 million. See individual financings below. Replication Medical, Inc., has raised $1.1 million in funding according to a regulatory filing (implantable hydrogel [...]
Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies. By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]
Asia-Pacific is a mix of a powerhouse country (Japan), a developing country with enormous market potential (China), a developing country with an arguably much smaller market potential (India), and a country that is more like the European Union in terms of healthcare spend (Australia). Japan is the second largest market for medical devices after the [...]
Cryotherapy is an exciting modality within the energy-based ablation device market, and is set to explode during the next ten years. It is being used primarily in cardiovascular, general surgery, cancer therapy and gynecology, and a good part of its use is thought to be off-label. Cryotherapy was little used in the EU until just [...]
Contact:
